These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 7738721)
1. Early increase precedes a depletion of endothelin-1 but not of von Willebrand factor in cutaneous microvessels of diabetic patients. A quantitative immunohistochemical study. Properzi G; Terenghi G; Gu XH; Poccia G; Pasqua R; Francavilla S; Polak JM J Pathol; 1995 Feb; 175(2):243-52. PubMed ID: 7738721 [TBL] [Abstract][Full Text] [Related]
2. Vascular wall von Willebrand factor in human diabetic retinopathy. Boeri D; Cagliero E; Podestá F; Lorenzi M Invest Ophthalmol Vis Sci; 1994 Feb; 35(2):600-7. PubMed ID: 8113010 [TBL] [Abstract][Full Text] [Related]
3. Intact microtubules are necessary for complete processing, storage and regulated secretion of von Willebrand factor by endothelial cells. Sinha S; Wagner DD Eur J Cell Biol; 1987 Jun; 43(3):377-83. PubMed ID: 3305020 [TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. Mathews MK; Merges C; McLeod DS; Lutty GA Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2729-41. PubMed ID: 9418725 [TBL] [Abstract][Full Text] [Related]
5. Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification. Chan NN; Fuller JH; Rubens M; Colhoun HM Med Sci Monit; 2003 Jul; 9(7):CR297-303. PubMed ID: 12883448 [TBL] [Abstract][Full Text] [Related]
7. Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications. De Mattia G; Bravi MC; Laurenti O; Moretti A; Cipriani R; Gatti A; Mandosi E; Morano S Diabetes Res Clin Pract; 2008 Feb; 79(2):337-42. PubMed ID: 17949845 [TBL] [Abstract][Full Text] [Related]
8. Endothelin-1-like immunoreactivity in human atherosclerotic coronary tissue: a detailed analysis of the cellular distribution of endothelin-1. Ihling C; Göbel HR; Lippoldt A; Wessels S; Paul M; Schaefer HE; Zeiher AM J Pathol; 1996 Jul; 179(3):303-8. PubMed ID: 8774487 [TBL] [Abstract][Full Text] [Related]
9. Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy. Roldán-Pallarés M; Rollín R; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R Retina; 2007 Feb; 27(2):222-35. PubMed ID: 17290206 [TBL] [Abstract][Full Text] [Related]
10. Retinopathy in type 2 diabetes mellitus is associated with increased intima-media thickness and endothelial dysfunction. Malecki MT; Osmenda G; Walus-Miarka M; Skupien J; Cyganek K; Mirkiewicz-Sieradzka B; damek-Guzik TA; Guzik TJ; Sieradzki J Eur J Clin Invest; 2008 Dec; 38(12):925-30. PubMed ID: 19021717 [TBL] [Abstract][Full Text] [Related]
11. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment. Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852 [TBL] [Abstract][Full Text] [Related]
12. [The change of plasma von Willebrand factor and endothelin levels in patients with pregnancy induced hypertension]. Wang C; Jin L; Chen J Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):212-4. PubMed ID: 11783363 [TBL] [Abstract][Full Text] [Related]
13. Study of endothelial t-PA and vWf in normal subjects and in von Willebrand's disease. Wieczorek I; Ludlam CA; MacGregor IR Blood Coagul Fibrinolysis; 1994 Jun; 5(3):329-34. PubMed ID: 8075304 [TBL] [Abstract][Full Text] [Related]
14. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy. Mastej K; Adamiec R Acta Diabetol; 2008 Sep; 45(3):183-90. PubMed ID: 18496641 [TBL] [Abstract][Full Text] [Related]
15. Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2. Klemm T; Mehnert AK; Siegemund A; Wiesner TD; Gelbrich G; Blüher M; Paschke R Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):568-72. PubMed ID: 16320153 [TBL] [Abstract][Full Text] [Related]
16. [Changes in microcirculation and selected laboratory parameters in the early stages of diabetic microangiopathy]. Skrha J; Prázný M; Kvasnicka J; Kalvodová B Cas Lek Cesk; 2001 Jun; 140(12):370-4. PubMed ID: 11503186 [TBL] [Abstract][Full Text] [Related]
17. Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients. THROMBO Investigators. Zareba W; Pancio G; Moss AJ; Kalaria VG; Marder VJ; Weiss HJ; Watelet LF; Sparks CE Thromb Haemost; 2001 Sep; 86(3):791-9. PubMed ID: 11583309 [TBL] [Abstract][Full Text] [Related]
18. Morphological changes of neural and vascular peptides in human skin suction blister injury. Gu XH; Terenghi G; Purkis PE; Price DA; Leigh IM; Polak JM J Pathol; 1994 Jan; 172(1):61-72. PubMed ID: 7931829 [TBL] [Abstract][Full Text] [Related]
19. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof]. Zhu H; Shi CH Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288 [TBL] [Abstract][Full Text] [Related]
20. von Willebrand factor in diabetic retinopathy. Abayomi EA; Miller E; Paton RC Cent Afr J Med; 1996 Jul; 42(7):205-6. PubMed ID: 8936786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]